Literature DB >> 16702878

Diagnostic challenges for Pompe disease: an under-recognized cause of floppy baby syndrome.

R Rodney Howell1, Barry Byrne, Basil T Darras, Priya Kishnani, Marc Nicolino, Ans van der Ploeg.   

Abstract

Pompe disease, a disorder caused by a deficiency in the lysosomal enzyme acid alpha glucosidase, is frequently overlooked as a cause of floppy baby syndrome. The accurate diagnosis of floppy baby syndrome requires the sequential evaluation of medical causes (e.g., hypothyroidism, sepsis, malnutrition, malabsorption, congenital heart disease), neurologic etiologies (central [cerebral] and peripheral [lower motor unit]) and anatomic characteristics of the abnormality. Cardiomegaly on chest x-ray in a patient with floppy baby syndrome should alert the pediatrician to suspect Pompe disease. Based on this finding, further work-up or referral to a specialist can be considered. Pompe disease requires immediate attention. Symptomatic intervention of this disorder should be initiated at the earliest time possible to maximize the potential benefit from therapy and to prevent irreversible organ damage. Moreover, early diagnosis is important for providing parents with realistic information about their child's prognosis, and where appropriate, professional genetic counseling. Enzyme replacement therapy (ERT) with recombinant human GAA is currently being evaluated in clinical trials; the future availability of this option makes early identification of this condition even more critical. This article presents a unified view on the optimal approach to the accurate diagnosis of Pompe disease and to its recognition as one of the possible and treatable causes of floppy baby syndrome.

Entities:  

Mesh:

Year:  2006        PMID: 16702878     DOI: 10.1097/01.gim.0000204462.42910.b8

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  12 in total

Review 1.  Lysosomal storage disorders in the newborn.

Authors:  Orna Staretz-Chacham; Tess C Lang; Mary E LaMarca; Donna Krasnewich; Ellen Sidransky
Journal:  Pediatrics       Date:  2009-04       Impact factor: 7.124

Review 2.  Pompe disease gene therapy.

Authors:  Barry J Byrne; Darin J Falk; Christina A Pacak; Sushrusha Nayak; Roland W Herzog; Melissa E Elder; Shelley W Collins; Thomas J Conlon; Nathalie Clement; Brian D Cleaver; Denise A Cloutier; Stacy L Porvasnik; Saleem Islam; Mai K Elmallah; Anatole Martin; Barbara K Smith; David D Fuller; Lee Ann Lawson; Cathryn S Mah
Journal:  Hum Mol Genet       Date:  2011-04-25       Impact factor: 6.150

Review 3.  Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy.

Authors:  Barry J Byrne; David D Fuller; Barbara K Smith; Nathalie Clement; Kirsten Coleman; Brian Cleaver; Lauren Vaught; Darin J Falk; Angela McCall; Manuela Corti
Journal:  Ann Transl Med       Date:  2019-07

Review 4.  Human-Induced Pluripotent Stem Cell-Based Modeling of Cardiac Storage Disorders.

Authors:  Bradley C Nelson; Sherin I Hashem; Eric D Adler
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

5.  Antenatal diagnosis of pompe disease by fetal echocardiography: impact on outcome after early initiation of enzyme replacement therapy.

Authors:  Mohamed A Hamdan; Bushra A El-Zoabi; Muzibunnisa A Begam; Hisham M Mirghani; Mohamed H Almalik
Journal:  J Inherit Metab Dis       Date:  2010-09-04       Impact factor: 4.982

6.  Early administration of enzyme replacement therapy for Pompe disease: short-term follow-up results.

Authors:  M A Hamdan; M H Almalik; H M Mirghani
Journal:  J Inherit Metab Dis       Date:  2008-12-12       Impact factor: 4.982

7.  Pompe disease diagnosis and management guideline.

Authors:  Priya S Kishnani; Robert D Steiner; Deeksha Bali; Kenneth Berger; Barry J Byrne; Laura E Case; Laura Case; John F Crowley; Steven Downs; R Rodney Howell; Richard M Kravitz; Joanne Mackey; Deborah Marsden; Anna Maria Martins; David S Millington; Marc Nicolino; Gwen O'Grady; Marc C Patterson; David M Rapoport; Alfred Slonim; Carolyn T Spencer; Cynthia J Tifft; Michael S Watson
Journal:  Genet Med       Date:  2006-05       Impact factor: 8.822

8.  A review of treatment of Pompe disease in infants.

Authors:  Yin-Hsiu Chien; Wuh-Liang Hwu
Journal:  Biologics       Date:  2007-09

9.  A 62-year-old man with dyspnea.

Authors:  Misbah Baqir; Jay H Ryu; Eric J Sorenson; Eric J Olson
Journal:  Respir Med Case Rep       Date:  2016-01-12

10.  Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing.

Authors:  Sébastien Lévesque; Christiane Auray-Blais; Elaine Gravel; Michel Boutin; Laura Dempsey-Nunez; Pierre-Etienne Jacques; Sébastien Chenier; Sandrine Larue; Marie-France Rioux; Walla Al-Hertani; Amelie Nadeau; Jean Mathieu; Bruno Maranda; Valérie Désilets; Paula J Waters; Joan Keutzer; Stephanie Austin; Priya Kishnani
Journal:  Orphanet J Rare Dis       Date:  2016-01-25       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.